Status: current, Defined. Date: 31-Jul 2021. Module: SNOMED CT core
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
4555155017 | Product containing precisely naloxegol (as naloxegol oxalate) 12.5 milligram/1 each conventional release oral tablet (clinical drug) | en | Fully specified name | Active | Case insensitive | SNOMED CT core |
4555156016 | Naloxegol (as naloxegol oxalate) 12.5 mg oral tablet | en | Synonym | Active | Case insensitive | SNOMED CT core |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Naloxegol (as naloxegol oxalate) 12.5 mg oral tablet | Has unit of presentation | Tablet | true | Inferred relationship | Some | ||
Naloxegol (as naloxegol oxalate) 12.5 mg oral tablet | Has manufactured dose form | Conventional release oral tablet | true | Inferred relationship | Some | ||
Naloxegol (as naloxegol oxalate) 12.5 mg oral tablet | Has presentation strength denominator unit | Tablet | true | Inferred relationship | Some | 1 | |
Naloxegol (as naloxegol oxalate) 12.5 mg oral tablet | Has BoSS | Naloxegol | true | Inferred relationship | Some | 1 | |
Naloxegol (as naloxegol oxalate) 12.5 mg oral tablet | Has presentation strength numerator unit | mg | true | Inferred relationship | Some | 1 | |
Naloxegol (as naloxegol oxalate) 12.5 mg oral tablet | Is a | Naloxegol only product in oral dose form | true | Inferred relationship | Some | ||
Naloxegol (as naloxegol oxalate) 12.5 mg oral tablet | Has precise active ingredient | Naloxegol oxalate | true | Inferred relationship | Some | 1 |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets